Roxadustat is an oral drug approved in various countries for anaemia treatment in adult NDD and DD-CKD patients. Credit: Steve Buissinne / Pixabay. The US Food and Drug Administration (FDA) has declined to approve the new drug application (NDA) for FibroGen’s roxadustat to treat anaemia in chronic kidney disease (CKD) patients.…